Last week’s ViVE conference in Los Angeles attracted hundreds of digital health startups, many of which were on the prowl for new customers and/or financing.
That means the health system executives and venture capital investors…
Experience the revolutionary potential of a cutting-edge PET tracer for early arthritis detection. Inflammatory arthritis, particularly rheumatoid arthritis, poses significant challenges due to its insidious onset and devastating consequences. This innovative PET imaging technique,…
Continue Reading
Headquartered in Scottsdale, Arizona, SimonMed is one of the largest outpatient medical imaging providers and radiology practices in the United States. It covers 10 states with more than 150 locations and more than 200…
Continue Reading
Artificial intelligence (AI)-assisted PET imaging is emerging as a promising tool for the diagnosis of Parkinson’s disease (PD). We aim to systematically review the diagnostic accuracy of AI-assisted PET in detecting PD. The Ovid…
Continue Reading
Neurophet scores $15M in Series C funding, announces 2024 IPOSouth Korean company Neurophet, a provider of brain image analysis software, has raised 20 billion won ($15 million) in a Series C funding round participated by…
Continue Reading
GE HealthCare announced a collaboration with Grand Rapids-based cancer treatment center BAMF Health to advance the adoption of theranostics in the U.S. Theranostics is an emerging technology and a form of precision medicine that fuses…
Continue Reading
GE HealthCare’s AI can accurately predict patient responses to immunotherapy, as demonstrated in collaborative studies with VUMC and UME. The models, showcasing 70-80% accuracy, may guide more personalized treatment decisions, potentially minimizing side effects…
Continue Reading
A new PET-CT scanner has been launched at Norfolk and Norwich University Hospital, to boost access to advanced cancer diagnostics in the East of England.The hospital has advanced its onsite PET-CT service, thanks to…
Continue Reading
Welcome to the first edition of our morning briefing of news, information and events for the digital health community. The briefing will be published every weekday morning.Your morning summary of digital health news, information…
Continue Reading
Blue Earth Diagnostics, a leading provider of PET radiopharmaceuticals, is set to present findings on POSLUMA (flotufolastat F 18) injection at the ASTRO 2023 Annual Meeting. POSLUMA aids in PET scans to detect prostate-specific…
Continue Reading
